Thierry Monney

Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Generation of high-expressing transposon-based stable pools to produce (1 + 1) and (2 + 1) bispecific common light chain antibodies.

Generation of high-expressing transposon-based stable pools to produce (1 + 1) and (2 + 1) bispecific common light chain antibodies.

Journal: Biotechnology progress
Published: October 28, 2025

Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidity.

Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidity.

Journal: mAbs
Published: January 30, 2025

ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells.

ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells.

Journal: Nature cancer
Published: October 09, 2023

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.

Journal: Nature communications
Published: July 31, 2023

Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma.

Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma.

Journal: Blood
Published: December 27, 2022

Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development.

Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development.

Journal: mAbs
Published: August 30, 2019

Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies.

Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies.

Journal: The Journal of biological chemistry
Published: February 21, 2017

Vaccines against neosporosis: what can we learn from the past studies?

Vaccines against neosporosis: what can we learn from the past studies?

Journal: Experimental parasitology
Published: September 24, 2013

Proteins mediating the Neospora caninum-host cell interaction as targets for vaccination.

Proteins mediating the Neospora caninum-host cell interaction as targets for vaccination.

Journal: Frontiers in bioscience (Elite edition)
Published: January 02, 2013

Use of a Th1 Stimulator Adjuvant for Vaccination against Neospora caninum Infection in the Pregnant Mouse Model.

Use of a Th1 Stimulator Adjuvant for Vaccination against Neospora caninum Infection in the Pregnant Mouse Model.

Journal: Pathogens (Basel, Switzerland)
Published: January 01, 2013

Differential Effects on Survival, Humoral Immune Responses and Brain Lesions in Inbred BALB/C, CBA/CA, and C57BL/6 Mice Experimentally Infected with Neospora caninum Tachyzoites.

Differential Effects on Survival, Humoral Immune Responses and Brain Lesions in Inbred BALB/C, CBA/CA, and C57BL/6 Mice Experimentally Infected with Neospora caninum Tachyzoites.

Journal: ISRN parasitology
Published: January 01, 2013

Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection.

Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection.

Journal: Vaccine
Published: March 26, 2012
Showing 1-12 of 14

Last Updated: 09/26/2026